NewsNovo Nordisk to Acquire Ocedurenone for Uncontrolled Hypertension By InvestLuck October 16, 2023 1 Mins read Novo Nordisk A/S (NVO) is set to acquire Ocedurenone, a promising pill with potential applications in cardiovascular and kidney disease, from KBP… Read more
